Article
Ethnic sensitive or molecular sensitive beyond all regions being equal in multiregional clinical trials.
Journal of biopharmaceutical statistics - 1 Sept 2012
Wang Sue-Jane, James Hung H M
Abstract excerpt
For decades, clinical trials have been the primary mechanism for medical products to enter the marketplace. Over more than a decade, globalization of medical product development via a multiregional clinical trial (MRCT) approach has generated greater enthusiasm because of tangible benefits in terms of cost and time for drug development. There are, however, many challenges including and not limited to design...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
